Short and long term vegetative growth response to temperature, interpreted by the dynamics of a carbohydrate storage

2014 ◽  
Vol 171 ◽  
pp. 14-26 ◽  
Author(s):  
Ido Seginer ◽  
Martin P.N. Gent
1991 ◽  
Vol 5 (4) ◽  
pp. 782-788 ◽  
Author(s):  
Michael S. Orfanedes ◽  
Loyd M. Wax

Field studies were conducted to compare the short- and long-term control of hemp dogbane by POST applications of Dowco 433, clopyralid, and 2,4-D amine. Dowco 433 at 140 g ae ha–1controlled 81 to 93% of weeds at 8 wk after treatment. Good control (79 to 89%) was also achieved with 560 g ae ha–12,4-D amine at 8 wk after treatment. Twelve months after treatment, control of hemp dogbane averaged 65 to 75% where Dowco 433 was applied at rates of 140 g ha–1or higher. Similar results were obtained with 2,4-D amine at 560 g ha–1. Control with clopyralid was minimal. Weed height and dry weight were reduced with all treatments except clopyralid. The effect of early versus late application was also evaluated in two studies. In certain situations, control 8 wk after treatment was greater when application was made during the early reproductive growth stage as opposed to the vegetative growth stage.


1998 ◽  
Vol 9 (10) ◽  
pp. 1899-1907
Author(s):  
D Haffner ◽  
E Wühl ◽  
F Schaefer ◽  
R Nissel ◽  
B Tönshoff ◽  
...  

To evaluate the growth-stimulating effects of short- and long-term treatment with recombinant human growth hormone (rhGH) in growth-retarded children with chronic renal failure (CRF), 103 prepubertal children with CRF on conservative treatment (n = 74) or dialysis (n = 29) were treated with rhGH for up to 5 yr. rhGH treatment persistently increased standardized height (+ 1.6 SD scores) and predicted adult height (+7.7 cm, Tanner method) during the first 3 treatment years (P < 0.001 versus baseline), followed by percentile parallel growth during continued treatment. Both standardized height and predicted adult height were significantly more increased in conservatively treated than in dialyzed children (P < 0.001). Age, GFR, target height, and prestudy growth rate were identified as independent predictors of the response to rhGH treatment during the first and second treatment year. GFR and target height were positively correlated with the change in height SD score and the change in absolute or age-standardized height velocity. Age affected the growth response depending on which outcome measure was used: Although the first-year change in height SD score was inversely correlated with age, the change in absolute height velocity was independent of age, and the change in standardized height velocity was positively correlated with age. The growth response during the first treatment year positively predicted the long-term response. In conclusion, the short- and long-term growth response to rhGH treatment in prepubertal growth-retarded children with CRF is significantly affected by age, GFR, target height, and the pretreatment growth rate. Therefore, rhGH should be preferably started at a young age, and early in the course of CRF.


Swiss Surgery ◽  
2001 ◽  
Vol 7 (1) ◽  
pp. 20-24 ◽  
Author(s):  
Robert ◽  
Mariéthoz ◽  
Pache ◽  
Bertin ◽  
Caulfield ◽  
...  

Objective: Approximately one out of five patients with Graves' disease (GD) undergoes a thyroidectomy after a mean period of 18 months of medical treatment. This retrospective and non-randomized study from a teaching hospital compares short- and long-term results of total (TT) and subtotal thyroidectomies (ST) for this disease. Methods: From 1987 to 1997, 94 patients were operated for GD. Thirty-three patients underwent a TT (mostly since 1993) and 61 a ST (keeping 4 to 8 grams of thyroid tissue - mean 6 g). All patients had received propylthiouracil and/or neo-mercazole and were in a euthyroid state at the time of surgery; they also took potassium iodide (lugol) for ten days before surgery. Results: There were no deaths. Transient hypocalcemia (< 3 months) occurred in 32 patients (15 TT and 17 ST) and persistent hypocalcemia in 8 having had TT. Two patients developed transient recurrent laryngeal nerve palsy after ST (< 3 months). After a median follow-up period of seven years (1-15) with five patients lost to follow-up, 41 patients having had a ST are in a hypothyroid state (73%), thirteen are euthyroid (23%), and two suffered recurrent hyperthyroidism, requiring completion of thyroidectomy. All 33 patients having had TT - with follow-ups averaging two years (0.5-8) - are receiving thyroxin substitution. Conclusions: There were no instances of persistent recurrent laryngeal nerve palsy in either group, but persistent hypoparathyroidism occurred more frequently after TT. Long after ST, hypothyroidism developed in nearly three of four cases, whereas euthyroidy was maintained in only one-fourth; recurrent hyperthyroidy was rare.


Author(s):  
Ian Neath ◽  
Jean Saint-Aubin ◽  
Tamra J. Bireta ◽  
Andrew J. Gabel ◽  
Chelsea G. Hudson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document